| |
| |
|
| Insider
Information: |
Martin John C |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,895,138 |
|
|
Indirect Shares
|
2,684,281 |
|
|
| Direct
Value |
$188,312,510 |
|
|
|
Indirect Value
|
$47,494,094 |
|
|
| Total
Shares |
5,579,419 |
|
|
| Total
Value |
$235,806,604 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Director |
2019-02-06 |
2,887,225 |
2016-08-05 |
731,917 |
Premium* |
|
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2021-03-03 |
7,913 |
2020-02-28 |
0 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
Director |
2020-10-14 |
0 |
2020-10-14 |
1,952,364 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
367 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 15 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-07-01 |
4 |
AS |
$51.95 |
$14,677,821 |
D/D |
(282,242) |
4,057,121 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-08-01 |
4 |
OE |
$7.63 |
$2,154,212 |
D/D |
282,242 |
4,339,363 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-08-01 |
4 |
AS |
$61.55 |
$17,389,740 |
D/D |
(282,242) |
4,057,121 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-09-03 |
4 |
OE |
$7.63 |
$2,154,212 |
D/D |
282,242 |
4,339,363 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-09-03 |
4 |
AS |
$60.95 |
$17,209,490 |
D/D |
(282,242) |
4,057,121 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-10-01 |
4 |
OE |
$7.63 |
$2,154,212 |
D/D |
282,242 |
4,339,363 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-10-01 |
4 |
AS |
$62.70 |
$17,696,545 |
D/D |
(282,242) |
4,057,121 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-11-01 |
4 |
AS |
$70.83 |
$19,990,213 |
D/D |
(282,242) |
4,057,121 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-11-01 |
4 |
OE |
$7.63 |
$2,154,212 |
D/D |
282,242 |
4,339,363 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-12-02 |
4 |
OE |
$7.63 |
$2,154,212 |
D/D |
282,242 |
4,339,363 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-12-02 |
4 |
AS |
$74.23 |
$20,960,697 |
D/D |
(282,242) |
4,057,121 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2014-11-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
306,400 |
4,122,987 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2014-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
360,000 |
4,617,235 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2015-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
376,846 |
4,500,081 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2016-08-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
731,917 |
3,287,810 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2016-08-05 |
4 |
A |
$0.00 |
$0 |
I/I |
731,917 |
731,917 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
Director |
– • – |
2020-10-14 |
4 |
A |
$0.00 |
$3,314,949 |
I/I |
1,876,564 |
1,876,564 |
0 |
- |
|
367 Records found
|
|
Page 15 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
